Literature DB >> 28459997

Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia.

Martina Minnerop1,2, Delia Kurzwelly2,3, Holger Wagner4, Anne S Soehn5, Jennifer Reichbauer6,7, Feifei Tao8, Tim W Rattay6,7, Michael Peitz3,9, Kristina Rehbach3,9, Alejandro Giorgetti10,11, Angela Pyle12, Holger Thiele13, Janine Altmüller13,14, Dagmar Timmann15, Ilker Karaca4, Martina Lennarz4, Jonathan Baets16,17,18, Holger Hengel6,7, Matthis Synofzik6,7, Burcu Atasu7,19, Shawna Feely20, Marina Kennerson21,22,23, Claudia Stendel24,25, Tobias Lindig26, Michael A Gonzalez8, Rüdiger Stirnberg3, Marc Sturm5, Sandra Roeske3, Johanna Jung3, Peter Bauer5, Ebba Lohmann7,17,27, Stefan Herms28,29,30, Stefanie Heilmann-Heimbach28,29, Garth Nicholson21,22,23, Muhammad Mahanjah31,32, Rajech Sharkia33,34, Paolo Carloni10, Oliver Brüstle3,9, Thomas Klopstock24,25,35, Katherine D Mathews36, Michael E Shy20, Peter de Jonghe16,17,18, Patrick F Chinnery12,37, Rita Horvath38, Jürgen Kohlhase39, Ina Schmitt2, Michael Wolf40, Susanne Greschus41, Katrin Amunts1,42, Wolfgang Maier3,4, Ludger Schöls6,7, Peter Nürnberg1,3,43,44, Stephan Zuchner8, Thomas Klockgether2,3, Alfredo Ramirez4,28,45, Rebecca Schüle6,7,8.   

Abstract

Despite extensive efforts, half of patients with rare movement disorders such as hereditary spastic paraplegias and cerebellar ataxias remain genetically unexplained, implicating novel genes and unrecognized mutations in known genes. Non-coding DNA variants are suspected to account for a substantial part of undiscovered causes of rare diseases. Here we identified mutations located deep in introns of POLR3A to be a frequent cause of hereditary spastic paraplegia and cerebellar ataxia. First, whole-exome sequencing findings in a recessive spastic ataxia family turned our attention to intronic variants in POLR3A, a gene previously associated with hypomyelinating leukodystrophy type 7. Next, we screened a cohort of hereditary spastic paraplegia and cerebellar ataxia cases (n = 618) for mutations in POLR3A and identified compound heterozygous POLR3A mutations in ∼3.1% of index cases. Interestingly, >80% of POLR3A mutation carriers presented the same deep-intronic mutation (c.1909+22G>A), which activates a cryptic splice site in a tissue and stage of development-specific manner and leads to a novel distinct and uniform phenotype. The phenotype is characterized by adolescent-onset progressive spastic ataxia with frequent occurrence of tremor, involvement of the central sensory tracts and dental problems (hypodontia, early onset of severe and aggressive periodontal disease). Instead of the typical hypomyelination magnetic resonance imaging pattern associated with classical POLR3A mutations, cases carrying c.1909+22G>A demonstrated hyperintensities along the superior cerebellar peduncles. These hyperintensities may represent the structural correlate to the cerebellar symptoms observed in these patients. The associated c.1909+22G>A variant was significantly enriched in 1139 cases with spastic ataxia-related phenotypes as compared to unrelated neurological and non-neurological phenotypes and healthy controls (P = 1.3 × 10-4). In this study we demonstrate that (i) autosomal-recessive mutations in POLR3A are a frequent cause of hereditary spastic ataxias, accounting for about 3% of hitherto genetically unclassified autosomal recessive and sporadic cases; and (ii) hypomyelination is frequently absent in POLR3A-related syndromes, especially when intronic mutations are present, and thus can no longer be considered as the unifying feature of POLR3A disease. Furthermore, our results demonstrate that substantial progress in revealing the causes of Mendelian diseases can be made by exploring the non-coding sequences of the human genome.
© The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  POLR3A; cerebellar ataxia; hereditary spastic paraplegia; leukodystrophy; spastic ataxia

Mesh:

Substances:

Year:  2017        PMID: 28459997      PMCID: PMC6402316          DOI: 10.1093/brain/awx095

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  39 in total

1.  Allegro, a new computer program for multipoint linkage analysis.

Authors:  D F Gudbjartsson; K Jonasson; M L Frigge; A Kong
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

2.  HaploPainter: a tool for drawing pedigrees with complex haplotypes.

Authors:  Holger Thiele; Peter Nürnberg
Journal:  Bioinformatics       Date:  2004-09-17       Impact factor: 6.937

3.  easyLINKAGE-Plus--automated linkage analyses using large-scale SNP data.

Authors:  K Hoffmann; T H Lindner
Journal:  Bioinformatics       Date:  2005-07-12       Impact factor: 6.937

4.  Characterization of the RNA polymerase II and III complexes in Leishmania major.

Authors:  Santiago Martínez-Calvillo; Alka Saxena; Amanda Green; Aaron Leland; Peter J Myler
Journal:  Int J Parasitol       Date:  2006-12-19       Impact factor: 3.981

Review 5.  The expanding RNA polymerase III transcriptome.

Authors:  Giorgio Dieci; Gloria Fiorino; Manuele Castelnuovo; Martin Teichmann; Aldo Pagano
Journal:  Trends Genet       Date:  2007-10-30       Impact factor: 11.639

6.  Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation.

Authors:  Gert C Scheper; Thom van der Klok; Rob J van Andel; Carola G M van Berkel; Marie Sissler; Joél Smet; Tatjana I Muravina; Sergey V Serkov; Graziella Uziel; Marianna Bugiani; Raphael Schiffmann; Ingeborg Krägeloh-Mann; Jan A M Smeitink; Catherine Florentz; Rudy Van Coster; Jan C Pronk; Marjo S van der Knaap
Journal:  Nat Genet       Date:  2007-03-25       Impact factor: 38.330

7.  The HHpred interactive server for protein homology detection and structure prediction.

Authors:  Johannes Söding; Andreas Biegert; Andrei N Lupas
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

8.  Tissue-specific differences in human transfer RNA expression.

Authors:  Kimberly A Dittmar; Jeffrey M Goodenbour; Tao Pan
Journal:  PLoS Genet       Date:  2006-11-13       Impact factor: 5.917

9.  qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data.

Authors:  Jan Hellemans; Geert Mortier; Anne De Paepe; Frank Speleman; Jo Vandesompele
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  PROMALS web server for accurate multiple protein sequence alignments.

Authors:  Jimin Pei; Bong-Hyun Kim; Ming Tang; Nick V Grishin
Journal:  Nucleic Acids Res       Date:  2007-04-22       Impact factor: 16.971

View more
  32 in total

1.  FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

Authors:  Tim W Rattay; Tobias Lindig; Jonathan Baets; Katrien Smets; Tine Deconinck; Anne S Söhn; Konstanze Hörtnagel; Kathrin N Eckstein; Sarah Wiethoff; Jennifer Reichbauer; Marion Döbler-Neumann; Ingeborg Krägeloh-Mann; Michaela Auer-Grumbach; Barbara Plecko; Alexander Münchau; Bernd Wilken; Marc Janauschek; Anne-Katrin Giese; Jan L De Bleecker; Els Ortibus; Martine Debyser; Adolfo Lopez de Munain; Aurora Pujol; Maria Teresa Bassi; Maria Grazia D'Angelo; Peter De Jonghe; Stephan Züchner; Peter Bauer; Ludger Schöls; Rebecca Schüle
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

Review 2.  Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways.

Authors:  Matthis Synofzik; Rebecca Schüle
Journal:  Mov Disord       Date:  2017-02-14       Impact factor: 10.338

3.  Reply: Complicated hereditary spastic paraplegia due to ATP13A2 mutations: what's in a name?

Authors:  Rebecca Schüle
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

4.  Reply: POLR3A variants in hereditary spastic paraplegia and ataxia.

Authors:  Martina Minnerop; Delia Kurzwelly; Tim W Rattay; Dagmar Timmann; Holger Hengel; Matthis Synofzik; Claudia Stendel; Rita Horvath; Rebecca Schüle; Alfredo Ramirez
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

5.  POLR3A variants in hereditary spastic paraplegia and ataxia.

Authors:  Laurence Gauquelin; Martine Tétreault; Isabelle Thiffault; Emily Farrow; Neil Miller; Byunggil Yoo; Eric Bareke; Grace Yoon; Oksana Suchowersky; Nicolas Dupré; Mark Tarnopolsky; Bernard Brais; Nicole I Wolf; Jacek Majewski; Guy A Rouleau; Ziv Gan-Or; Geneviève Bernard
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

6.  POLR3A-Related Disorder Presenting with Late-Onset Dystonia and Spastic Paraplegia.

Authors:  Paula Camila Alves de Assis Pereira Matos; Maria Thereza Drumond Gama; Márcio Luiz Escórcio Bezerra; Antônio José da Rocha; Orlando G P Barsottini; José Luiz Pedroso
Journal:  Mov Disord Clin Pract       Date:  2020-04-18

Review 7.  [Genetics of tremor].

Authors:  G Kuhlenbäumer; F Hopfner
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

8.  SPTAN1 variants as a potential cause for autosomal recessive hereditary spastic paraplegia.

Authors:  Etienne Leveille; Mehrdad A Estiar; Lynne Krohn; Dan Spiegelman; Alexandre Dionne-Laporte; Nicolas Dupré; Jean François Trempe; Guy A Rouleau; Ziv Gan-Or
Journal:  J Hum Genet       Date:  2019-09-12       Impact factor: 3.172

9.  The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes.

Authors:  Lorena Travaglini; Chiara Aiello; Fabrizia Stregapede; Adele D'Amico; Viola Alesi; Andrea Ciolfi; Alessandro Bruselles; Michela Catteruccia; Simone Pizzi; Ginevra Zanni; Sara Loddo; Sabina Barresi; Gessica Vasco; Marco Tartaglia; Enrico Bertini; Francesco Nicita
Journal:  Neurogenetics       Date:  2018-04-24       Impact factor: 2.660

Review 10.  Molecular genetic testing for hereditary ataxia: What every neurologist should know.

Authors:  Stephanie E Wallace; Thomas D Bird
Journal:  Neurol Clin Pract       Date:  2018-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.